First Time Loading...

23andMe Holding Co.
NASDAQ:ME

Watchlist Manager
23andMe Holding Co. Logo
23andMe Holding Co.
NASDAQ:ME
Watchlist
Price: 0.5023 USD -0.46% Market Closed
Updated: May 4, 2024

23andMe Holding Co.
Operating Income

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

23andMe Holding Co.
Operating Income Peer Comparison

Comparables:
DVA
DGX
CVS
CI
LH

Competitive Operating Income Analysis
Latest Figures & CAGR of Competitors

Company Operating Income CAGR 3Y CAGR 5Y CAGR 10Y
23andMe Holding Co.
NASDAQ:ME
Operating Income
-$324m
CAGR 3-Years
-15%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
DaVita Inc
NYSE:DVA
Operating Income
$1.6B
CAGR 3-Years
-2%
CAGR 5-Years
1%
CAGR 10-Years
-1%
Quest Diagnostics Inc
NYSE:DGX
Operating Income
$1.3B
CAGR 3-Years
-20%
CAGR 5-Years
1%
CAGR 10-Years
2%
CVS Health Corp
NYSE:CVS
Operating Income
$13.6B
CAGR 3-Years
-1%
CAGR 5-Years
3%
CAGR 10-Years
5%
Cigna Corp
NYSE:CI
Operating Income
$9B
CAGR 3-Years
2%
CAGR 5-Years
14%
CAGR 10-Years
15%
Laboratory Corporation of America Holdings
NYSE:LH
Operating Income
$1.1B
CAGR 3-Years
-34%
CAGR 5-Years
-5%
CAGR 10-Years
2%

See Also

What is 23andMe Holding Co.'s Operating Income?
Operating Income
-324m USD

Based on the financial report for Mar 31, 2023, 23andMe Holding Co.'s Operating Income amounts to -324m USD.

What is 23andMe Holding Co.'s Operating Income growth rate?
Operating Income CAGR 3Y
-15%

Over the last year, the Operating Income growth was -27%. The average annual Operating Income growth rates for 23andMe Holding Co. have been -15% over the past three years .